Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

High-Power Laser Therapy for Notalgia Paresthetica

Official title: The Effectiveness of High-power Laser Therapy in the Treatment of Notalgia Paresthetica: A Randomised Controlled Study.

Run by Uşak University · NCT07356362 · Data updated 2026-11-12

This study tests whether adding High-Power Laser Therapy to standard care can reduce itching and pain for adults with long-standing Notalgia Paresthetica.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorUşak University
Academic / other
Locations1 site (Uşak)
StatusRecruiting
StartedJuly 17, 2026
Main results expectedOctober 23, 2026
Study endsNovember 12, 2026
Registry record updatedJuly 20, 2026
Trial IDNCT07356362 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-75 with unilateral NP for at least 3 months and a NRS pruritus score of 4 or higher in the affected area.

Probably not a fit

Patients without a favorable response to laser therapy or with exclusion criteria may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, assessor-blinded trial evaluates high-power laser therapy as an adjunct to standard care for notalgia paresthetica. Eligible adults with unilateral symptoms for at least 3 months and a minimum pruritus score will receive either active high-power laser treatment or sham laser, alongside their usual care. The study aims to measure changes in itching, pain, and quality of life over the treatment period. Outcomes will help determine if HPLT provides meaningful relief beyond standard therapies. The design addresses a gap in evidence for non-invasive options in this chronic neuropathic condition.

Why it matters

Potential benefit: If successful, participants could experience reduced itching and pain and improved daily functioning.

How similar studies have gone: Previous reports on HPLT for NP are limited; this trial seeks to provide more rigorous evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-75 years
* Clinical diagnosis of unilateral Notalgia Paresthetica for at least 3 months
* Presence of characteristic symptoms (pruritus, paresthesia, and/or burning pain) in the typical T2-T6 dermatomal distribution
* A minimum score of 4 on the Numeric Rating Scale (NRS) for pruritus intensity
* Presence of hyperpigmentation in the affected area

Exclusion Criteria:

* \- Secondary causes of symptoms (e.g., spinal pathology, herpes zoster, renal failure)
* Previous spinal surgery in the thoracic region
* Coagulopathy or use of anticoagulant medication
* Skin diseases or infections in the treatment area
* Pregnancy or lactation
* Cognitive impairment affecting ability to complete questionnaires
* Previous treatment with botulinum toxin in the affected area within 6 months

Where it's running

  • Usak University
    Uşak, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.